|
(Health-NewsWire.Net, July 09, 2015 ) The analysts forecast global opioid-induced constipation market to grow at a CAGR of 30.18% over the period 2014-2019.
Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. The opioid analgesics produce analgesia by the activation of the mu receptors found in the CNS and PNS. These drugs affect the motility, tone, and contractility of the bowel functions, which results in the delay in the transit of fecal contents. The opioids also cause a reduction in the secretion of digestive enzymes and also cause partial gastroparesis. Some of the common symptoms of opioid-induced constipation are hard and dry stools, painful defecation, bloating, distention and bulged abdomen, feeling lethargic, and loss of appetite. Opioid-induced constipation can be managed by changing lifestyle along with the use of targeted therapies and other OTC and off-label drugs.
Covered in this Report
This report covers the present scenario and the growth prospects of the global opioid-induced constipation market for 2015-2019. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of opioid-induced constipation, which includes branded drugs, off-label products, and OTC drugs.
Purchase a Report Copy at http://www.rnrmarketresearch.com/contacts/purchase?rname=394276 .
On the basis of the mechanism of action of drugs, the market is grouped into the following categories:
Peripherally Acting Mu-opioid Receptor Antagonist
Locally Acting Chloride Channel Activator
Others
On the basis of the route of administration of drugs, the market is grouped into the following categories:
Oral
Parenteral
On the basis of the dosage form of drugs, the market is grouped into the following categories:
Solid
Liquid
The report, Global Opioid-induced Constipation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
APAC
EMEA
Key Vendors
AstraZeneca
Takeda Pharmaceutical
Valeant Pharmaceuticals International
Inquire before Buying at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=394276 .
Other Prominent Vendors
Abbott
Bayer
Boehringer Ingelheim
C.B. Fleet
Cosmo Pharmaceuticals
Daewoong
Daiichi Sankyo
GlaxoSmithKline
Ironwood Pharmaceuticals
Johnson & Johnson
Merck
Mundipharma
Nektar Therapeutics
Pfizer
Progenics Pharmaceuticals
Shionogi
SLA Pharma
Sucampo
Synergy Pharmaceuticals
Theravance
Market Driver
Unmet Medical Needs
Market Challenge
Availability of OTC and Off-label Drugs
Market Trend
Shift to Targeted Therapy
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=394276 .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
